about
The next generation of risk assessment multiyear study - highlights of findings, applications to risk assessment, and future directionsHistone acetylation: novel target for the treatment of acute lymphoblastic leukemiaBeyond the genome: epigenetic mechanisms in lung remodelingAltered histone modifications in gliomasRewriting the epigenetic code for tumor resensitization: a review.Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P + cells through epigenetics modifications.Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies.In vitro evaluation of low-intensity light radiation on murine melanoma (B16F10) cells.Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer.Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway.Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.Genomic tools in acute myeloid leukemia: From the bench to the bedsideEpigenetics in lung cancer diagnosis and therapy.The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies.Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.Rewiring the solid tumor epigenome for cancer therapy.Identification of proteins related to epigenetic regulation in the malignant transformation of aberrant karyotypic human embryonic stem cells by quantitative proteomics.The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.The epigenetic basis of cellular plasticity.p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.Epigenetic therapies - a new direction in clinical medicine.
P2860
Q26357739-AA17F04D-935C-4842-9EB8-FD7677096F34Q26778780-E3454ABA-4D6F-46A8-93A2-41D1657DA9CAQ27021767-754DC766-1CA4-4B2E-8631-81BB40418AE3Q27027924-76133F37-2096-402A-B10B-8F2BDE6789DBQ27687583-63476F28-0FC8-4C8D-92F3-517F376FFD23Q33803967-F09D72C4-4E50-4ABC-97E1-0CDD8A9645BEQ35582225-D208B26F-C83D-4497-B8E5-668EFDC93AA5Q35639928-06B0A4DE-52B5-465F-B9CE-2C4EAFB7B507Q35726371-7EC36C19-DF7A-4AED-B96C-2221E492CC6DQ36672248-8F0BA6C7-2A05-4665-9295-21EA6244CE36Q37600405-808E9D08-3EA3-4B3F-9C11-8BCAFE263ABCQ37719054-35291A74-0B7A-4729-80A3-1CC921982AD5Q38182932-714711FA-5338-41ED-8520-CAB7B6675E3AQ38457939-127EF614-E30E-457D-89EA-68C8CEEE71BDQ38591064-21BF1590-7017-450B-BB96-8C7204933048Q38595978-20EE0A88-F577-46B1-B036-727EDB43FA0AQ38641499-5B4D6D13-4696-431D-8ECE-BA73DA56846DQ38833930-CC293FEF-B21B-4E31-802D-1AF91E0952CBQ38895216-3622AF1C-916A-4D22-B523-E3B28A4BC17CQ39030316-E68CB17F-FAE7-4D34-941A-47CAF94253BCQ39271171-2A7E1489-7D8B-45BB-9C9A-EEA753BD481DQ41843735-C0BDA81F-0CAB-43A6-B006-335A3F1959BEQ50136682-EF8D7EE2-A8EB-4782-81F5-7F4170E7FCB2Q51026395-90AFD876-3009-4882-BF36-1FF4018F83CBQ51733858-3F3DBE3B-AF90-4B68-A825-252D3D52BA07
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cancer epigenetics: new therapies and new challenges.
@en
Cancer epigenetics: new therapies and new challenges.
@nl
type
label
Cancer epigenetics: new therapies and new challenges.
@en
Cancer epigenetics: new therapies and new challenges.
@nl
prefLabel
Cancer epigenetics: new therapies and new challenges.
@en
Cancer epigenetics: new therapies and new challenges.
@nl
P2860
P356
P1476
Cancer epigenetics: new therapies and new challenges
@en
P2093
P2860
P304
P356
10.1155/2013/529312
P577
2013-02-26T00:00:00Z